Newtopia
Newtopia delivers highly personalized and targeted disease prevention solutions to reduce healthcare costs.
Launch date
Employees
Market cap
AUD2.0m
Enterprise valuation
AUD13m (Public information from Sep 2024)
Share price
CAD0.01 NEWU.V
Toronto Ontario (HQ)
Financials
Estimates*
CAD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Revenues | 6.1m | 11.4m | 10.5m | 11.2m | 14.3m | 25.2m | 36.1m |
% growth | 99 % | 87 % | (8 %) | 7 % | 28 % | 76 % | 43 % |
EBITDA | (7.5m) | (6.6m) | (7.2m) | (6.7m) | - | - | - |
% EBITDA margin | (123 %) | (58 %) | (69 %) | (60 %) | - | - | - |
Profit | (10.1m) | (7.7m) | (7.6m) | (7.7m) | - | - | - |
% profit margin | (166 %) | (68 %) | (73 %) | (69 %) | - | - | - |
EV / revenue | - | 6.6x | 4.3x | 1.8x | 1.6x | - | - |
EV / EBITDA | - | -11.3x | -6.2x | -3.1x | - | - | - |
R&D budget | 2.5m | 3.4m | <1m | 1.4m | - | - | - |
R&D % of revenue | 41 % | 30 % | 4 % | 12 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$1.0m | Angel | ||
$1.1m | Angel | ||
N/A | $20.0k | Grant | |
N/A | Early VC | ||
$2.0m | Early VC | ||
$10.0m | Series A | ||
N/A | Late VC | ||
N/A | N/A | IPO | |
* | N/A | $747k | Private Placement VC |
* | CAD200k | Post IPO Debt | |
Total Funding | AUD23.1m |